Cementic is a biotech start-up founded in 2016. At Cementic, we develop innovative solutions based on the latest nano-biotechnologies to solve dental health issues with a new paradigm.
Dr. RADDI has a double degree in dental surgery and bioengenering research. He is the inventor of the key patented technology. He is involved in bone regeneration research at the laboratory UMR CNRS 7052, along with a private dental practice specializing in oral surgery.
M. Cauche brings 25+ years of experience in the medical device industry across Europe and North America . His marketing and strong sales experience, combined with robust management and financial skills have helped him manage top teams in several different companies. These include Dentsply, Sirona, Henry Shein, and most recently Align Technologies ( Future's Fortune 500)
Integration of biodegradable lipid nanoparticles to deliver a sustained release of antiseptic from a mineral bone and dental biomaterial.
Root canal procedure : Cementic provides a strong antibacterial effect of the cement that fills the tooth and avoids post treatment infection. Pre-clinical results show that our formulation kills 99.99% of resistant bacteria even after 14 days. Regulatory route has been confirmed and a first market introduction is expected in 2025.
Bone grafting procedure: Cementic is working on a prototype to integrate its technology into bone fillers to reduce post surgical infection.
138 Rue Du Faubourg Saint-Honoré, 75008 Paris, France
Copyright © 2021 Cementic - All Rights Reserved.